Eph tumour suppression: the dark side of Gleevec
- PMID: 16880809
- DOI: 10.1038/ncb0806-785
Eph tumour suppression: the dark side of Gleevec
Comment on
-
The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl-Crk pathway.Nat Cell Biol. 2006 Aug;8(8):815-25. doi: 10.1038/ncb1438. Epub 2006 Jul 23. Nat Cell Biol. 2006. PMID: 16862147
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
